US Stocks
BCLI
Brainstorm Cell Therapeutics Inc.
$0.7917
+0.0000 (+0.00%)
Volume:
0 ($0.00)
Market Capitalization:
-
Brainstorm Cell Therapeutics Price Chart
*There is no price data available for this ticker
Brainstorm Cell Therapeutics Volume Chart
*There is no volume data available for this ticker
Brainstorm Cell Therapeutics Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
*No Trades in Segment
Premarket Yesterday
*No Trades in Segment
Brainstorm Cell Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Brainstorm Cell Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $0.7415 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.7165 |
| 20 Day Moving Average (SMA20) | $0.7025 |
| 50 Day Moving Average (SMA50) | $0.7810 |
| 100 Day Moving Average (SMA100) | $0.7112 |
| 200 Day Moving Average (SMA200) | $0.6833 |
Brainstorm Cell Therapeutics Statistics
| Average Volume (30 Days) | 11.61K |
|---|---|
| P/E Ratio (Current) | -.73 |
| EPS (Current) | -$1.16 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$9.49M |
| Cash Ratio | 0.10 |
| Current Ratio | 0.18 |
| Quick Ratio | 0.18 |
| Debt to Equity | -0.02 |
| Enterprise Value | $7.64M |
| EV to EBITDA | -0.65 |
| EV to Sales | — |
| Price to Book | -1.38 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -4.46% |
| Return on Equity | 1.89% |
Brainstorm Cell Therapeutics Stock Splits
There have been 2 stock splits for Brainstorm Cell Therapeutics (BCLI). The last reverse stock split occured on October 1, 2024 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Oct 1, 2024 | Reverse | 15:1 |
| Sep 16, 2014 | Reverse | 15:1 |
Brainstorm Cell Therapeutics Dividends
There have been no dividends for Brainstorm Cell Therapeutics (BCLI).